Announced
Completed
Synopsis
AIX Ventures, a venture capital firm, led a $20.4m in Series A round in Ataraxis AI, a NYC-based AI precision medicine company, with participation from Floating Point, Thiel Bio, Founders Fund, Bertelsmann Investments, Giant Ventures, Obvious Ventures, Mario Schlosser, and Ryan Fukushima.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Seller Team (2)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite